Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105884781B details a chiral catalytic route for Tofacitinib Citrate, offering high purity and cost reduction in pharmaceutical intermediates manufacturing for global supply chains.
Patent CN102603714B details a high-yield asymmetric oxidation method for PPI intermediates. Discover cost-effective manufacturing and supply chain advantages.
Novel chiral catalytic route for Tofacitinib Citrate. Enhances purity, reduces cost, ensures supply chain reliability for pharmaceutical manufacturing.
Patent CN103951588A reveals a novel chiral squaramide catalytic route for saxagliptin intermediates, offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Patent CN103275108B details a one-step chiral copper complex synthesis offering simplified manufacturing and potential cost reduction for pharmaceutical intermediate supply chains.
Patent CN1281587C details a chiral phase transfer catalysis method for single isomer nitrendipine. Achieve high purity and reduced impurities for cardiovascular API manufacturing.
Patent CN101323609A details a novel asymmetric oxidation method for high-purity PPI intermediates, offering significant cost reduction and supply chain reliability.
Discover the novel asymmetric synthesis of Triptolide via chiral phase transfer catalysis. Enhance supply chain reliability and reduce costs in API manufacturing with our scalable route.
Patent CN102381990A details a cost-effective Ruthenium-catalyzed asymmetric hydrogenation route for N-benzyl phenylephrine intermediates, offering superior purity and supply chain reliability.
Novel chiral phase transfer catalysis method for L-phosphinothricin. Reduces cost and improves yield for agrochemical intermediate manufacturing supply chains.
Patent CN118638038A reveals mild catalytic synthesis for high-purity pharmaceutical intermediates with significant cost reduction and supply chain reliability advantages.
Patent CN115850336B reveals metal-free synthesis for high-purity axial chiral compounds. Enables cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Patent CN103044402B details a low-cost chiral oxidation route for Esomeprazole Sodium, offering high purity and supply chain stability for API manufacturing.
Novel chiral intermediate synthesis for Moxifloxacin. High purity, scalable process, cost-effective manufacturing solution for global supply chains.
Patent CN1926083B details a novel ruthenium-catalyzed asymmetric hydrogenation method for producing high-purity optically active alcohols with superior stereoselectivity and yield.
Novel chiral phosphoric acid catalyzed method offers high yield and mild conditions for pharmaceutical intermediate manufacturing supply chain optimization and reliability.
Patent CN103102231B reveals a one-step chiral Lewis acid catalyzed route for high-purity 4-hydroxypiperidine intermediates, offering significant cost reduction and scalable manufacturing for global supply chains.
Patent CN109942514A reveals efficient Ir-catalyzed route for Atazanavir intermediate. Enables cost reduction in API manufacturing and reliable supply chain continuity.
Patent CN111333573A details a robust asymmetric hydrogenation process for dextromethorphan intermediates, offering superior enantioselectivity and scalable manufacturing advantages.
Patent CN102264672A details a scalable route to chiral phenols using Ru-catalyzed transfer hydrogenation, offering cost reduction and high purity for pharmaceutical manufacturing.